Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Amy Lwin

Single- And Multiple-Dose Pharmacokinetics and Safety of Pimodivir, a Novel, Non-Nucleoside Polymerase Basic Protein 2 Subunit Inhibitor of the Influenza a Virus Polymerase Complex, and Interaction With Oseltamivir: A Phase 1 Open-Label Study in Healthy V

British Journal of Clinical Pharmacology

Pharmacology

2018

English

Related publications

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Dose JPI-289, a Novel Poly (ADP-Ribose) Polymerase-1 Inhibitor in First-In-Human Study of Healthy Volunteers

Clinical Therapeutics

Pharmacology

2017

English

Correction To: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-In-Human, Single- And Multiple-Dose Study in Healthy Volunteers

Clinical Drug Investigation

Medicine

Pharmacology

2019

English

Mechanism of Inhibition for BMS-791325, a Novel Non-Nucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase

Journal of Biological Chemistry

English

Cellular Protein HAX1 Interacts With the Influenza a Virus PA Polymerase Subunit and Impedes Its Nuclear Translocation

English

Single-Dose Safety, Tolerability, and Pharmacokinetics of the Antibiotic GSK1322322, a Novel Peptide Deformylase Inhibitor

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2013

English

Single and Multiple Dose Pharmacokinetics And tolerability of HX-1171, a Novel Antioxidant, in Healthy Volunteers

Drug Design, Development and Therapy

Drug Discovery

Pharmacology

Pharmaceutical Science

2015

English

In Silico Screening for Human Norovirus Antivirals Reveals a Novel Non-Nucleoside Inhibitor of the Viral Polymerase

Scientific Reports

Multidisciplinary

2018

English

An Open-Label, Single-Treatment, Single-Period, Single Dose, Clinical Phase 1 Study to Assess the Safety and Tolerability of Tetanus Vaccine in Healthy, Adult Subjects in India

Journal of Evidence Based Medicine and Healthcare

2019

English

The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function

PLoS ONE

Multidisciplinary

2012

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Amy Lwin

Single- And Multiple-Dose Pharmacokinetics and Safety of Pimodivir, a Novel, Non-Nucleoside Polymerase Basic Protein 2 Subunit Inhibitor of the Influenza a Virus Polymerase Complex, and Interaction With Oseltamivir: A Phase 1 Open-Label Study in Healthy V

Related publications

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Dose JPI-289, a Novel Poly (ADP-Ribose) Polymerase-1 Inhibitor in First-In-Human Study of Healthy Volunteers

Correction To: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-In-Human, Single- And Multiple-Dose Study in Healthy Volunteers

Mechanism of Inhibition for BMS-791325, a Novel Non-Nucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase

Cellular Protein HAX1 Interacts With the Influenza a Virus PA Polymerase Subunit and Impedes Its Nuclear Translocation

Single-Dose Safety, Tolerability, and Pharmacokinetics of the Antibiotic GSK1322322, a Novel Peptide Deformylase Inhibitor

Single and Multiple Dose Pharmacokinetics And&nbsp;tolerability of HX-1171, a Novel Antioxidant, in Healthy Volunteers

In Silico Screening for Human Norovirus Antivirals Reveals a Novel Non-Nucleoside Inhibitor of the Viral Polymerase

An Open-Label, Single-Treatment, Single-Period, Single Dose, Clinical Phase 1 Study to Assess the Safety and Tolerability of Tetanus Vaccine in Healthy, Adult Subjects in India

The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function

Single and Multiple Dose Pharmacokinetics And tolerability of HX-1171, a Novel Antioxidant, in Healthy Volunteers